Augmentation of antidepressant effects of duloxetine and bupropion by caffeine in mice PP Kale, V Addepalli Pharmacology Biochemistry and Behavior 124, 238-244, 2014 | 46 | 2014 |
ROS responsive mesoporous silica nanoparticles for smart drug delivery: A review V Daund, S Chalke, AP Sherje, PP Kale Journal of Drug Delivery Science and Technology 64, 102599, 2021 | 31 | 2021 |
Combinational approaches targeting neurodegeneration, oxidative stress, and inflammation in the treatment of diabetic retinopathy SD Chalke, PP Kale Current Drug Targets 22 (16), 1810-1824, 2021 | 23 | 2021 |
Mini review–vanadium-induced neurotoxicity and possible targets MR Jaiswal, PP Kale Neurological Sciences 41 (4), 763-768, 2020 | 22 | 2020 |
Potentiation of antidepressant effects of agomelatine and bupropion by hesperidin in mice JS Nadar, PP Kale, PK Kadu, K Prabhavalkar, R Dhangar Neurology Research International 2018 (1), 9828639, 2018 | 16 | 2018 |
Caffeine-induced augmentation of antidepressant therapy PP Kale, V Addepalli, PA Bafna, KS Prabhavalkar Journal of Experimental & Clinical Medicine 2 (6), 282-286, 2010 | 16 | 2010 |
Evaluation of anxiolytic effects of aripiprazole and hydroxyzine as a combination in mice NS Sawantdesai, PP Kale, J Savai Journal of basic and clinical pharmacy 7 (4), 97, 2016 | 15 | 2016 |
An update on novel therapeutic intervention in Rheumatoid arthritis P Shah, A Siddique, A Thakkar, S Gharat, A Godad, P Kale, G Doshi International Immunopharmacology 109, 108794, 2022 | 13 | 2022 |
Impact of pre-exposure of tail suspension on behavioural parameters like locomotion, exploration, and anxiety in mice PP Kale, V Addepalli, SR Ghadawale NISCAIR-CSIR, India, 2013 | 12 | 2013 |
Herbal approach in the treatment of pancytopenia SM Bagwe, PP Kale, LK Bhatt, KS Prabhavalkar Journal of Complementary and Integrative Medicine 14 (1), 20160053, 2017 | 11 | 2017 |
Copper-lowering agents as an adjuvant in chemotherapy P Kadu, B Sawant, PP Kale, K Prabhavalkar Indian Journal of Pharmacology 53 (3), 221-225, 2021 | 10 | 2021 |
Importance of exploring n-methyl-d-aspartate (NMDA) as a future perspective target in depression NY Bhatia, HS Ved, PP Kale, GM Doshi CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2022 | 9 | 2022 |
Assessment of antidiabetic activity of combination of Murraya koenigii leaves extract and Vitis vinifera seeds extract in alloxan-induced diabetic rats SM Palwankar, PP Kale, PK Kadu, K Prabhavalkar Journal of Reports in Pharmaceutical Sciences 9 (1), 79-85, 2020 | 8 | 2020 |
Effect of a combination of duloxetine with hydroxyzine on experimental models of anxiety in mice S Patel, PP Kale, V Addepalli, A Sarkar, J Savai Indian Journal of Pharmacology 47 (2), 173-176, 2015 | 8 | 2015 |
The combination of antidepressant duloxetine with Piracetam in mice does not produce enhancement of Nootropic activity PP Kale, V Addepalli, A Sarkar, S Patel, J Savai Experimental Neurobiology 23 (3), 224, 2014 | 8 | 2014 |
Effect of Withania somnifera (L.) Dunal aqueous root extract on reinstatement using conditioned place preference and brain GABA and dopamine levels in alcohol dependent animals PA Marathe, SD Satam, SB Raut, YC Shetty, SG Pooja, AA Raut, PP Kale, ... Journal of Ethnopharmacology 274, 113304, 2021 | 7 | 2021 |
Effect of bupropion augmentation with minocycline in the treatment of depression. KPP Bendale M, D'souza, Addepalli V Acta Neurobiologiae Experimentalis 79, 217-224, 2019 | 6 | 2019 |
Mini review–The role of Glucocerebrosidase and Progranulin as possible targets in the treatment of Parkinson's disease PS Rodrigues, PP Kale Revue neurologique 177 (9), 1082-1089, 2021 | 5 | 2021 |
Enhancement of nootropic effect of duloxetine and bupropion by caffeine in mice PP Kale, V Addepalli Indian Journal of Pharmacology 47 (2), 199-201, 2015 | 5 | 2015 |
Possible benefits of considering glutamate with melatonin or orexin or oxytocin as a combination approach in the treatment of anxiety RR Dhangar, PP Kale, PK Kadu, K Prabhavalkar Current Pharmacology Reports 6, 1-7, 2020 | 4 | 2020 |